Breaking News, Collaborations & Alliances

Ship of Theseus Taps Charles River as Manufacturing Partner

Charles River to support the development of novel HOX-based therapies through plasmid DNA manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

Charles River Laboratories International, Inc. and Ship of Theseus, a therapeutics company developing degradation-resistant homeobox (HOX) family biologics, have announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement under which Ship of Theseus will leverage Charles River’s expertise to manufacture GMP plasmid DNA to serve as the active drug substance for its lead candidate.   Ship of Theseus is developing a proprietary s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters